Squarepoint Ops LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in DYN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,664,643

-$8,458,967 QoQ

Shares Held

300,074

-64.0% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#65

of 245 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. DYN ranks #43 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,664,643	300,074	-64.0%	Shares	Defined	2026-08-14
2026-03-31	$15,123,610	834,176	+226.9%	Shares	Defined	2026-05-15
2025-12-31	$4,990,929	255,160	+436.1%	Shares	Defined	2026-02-13
2025-09-30	$602,038	47,592	-73.8%	Shares	Defined	2025-11-14
2025-06-30	$1,730,164	181,740	+334.3%	Shares	Defined	2025-08-27
2025-03-31	$437,688	41,844	-18.9%	Shares	Defined	2025-08-27
2024-12-31	$1,216,072	51,616	-38.0%	Shares	Defined	2025-02-14
2024-09-30	$2,989,585	83,229	+84.2%	Shares	Defined	2024-11-14
2024-06-30	$1,594,966	45,196	-42.9%	Shares	Defined	2024-08-14
2024-03-31	$2,247,920	79,180	+132.5%	Shares	Defined	2024-05-15
2023-06-30	$383,208	34,063	+39.8%	Shares	Defined	2023-08-14
2023-03-31	$280,650	24,362	+5.1%	Shares	Defined	2023-05-15
2020-09-30	$467,883	23,174	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.